Apollo Micro Systems Limited sees a credit rating action

The exchange filing does not report any specific debt-structure shift—such as higher working-capital utilisation, increased short-term borrowing, or a maturity mismatch—as the primary reason for the revision.

It only records CAREedge’s revised/watch status:

• Long-term bank facilities of Rs 1,530 Crores: CARE A- (RWD).
• Short-term bank facilities of Rs 350 Crores: CARE A2+ (RWD). ^[1]
• The rating communication was received from CAREedge on 26 August 2026. ^[1]

Accordingly, attributing the revision specifically to increased working-capital-limit utilisation or greater reliance on short-term debt would go beyond the disclosed filing. The underlying CAREedge rationale would be required to identify the precise debt and liquidity drivers.

Bottom line: The revised rating should not automatically reprice Apollo Micro Systems’ existing borrowings, but the “Rating Watch with Developing implications” (RWD) introduces uncertainty for fresh sanctions and renewals. The likely near-term effect is greater lender scrutiny, with potential pressure on pricing, collateral or cash-margin requirements for additional bank guarantees; however, the filing does not establish that any facility has already been repriced or withdrawn.

On 27 August 2026, CARE assigned CARE A- (RWD) to Rs 1,530 Crores of long-term bank facilities and CARE A2+ (RWD) to Rs 350 Crores of short-term bank facilities—an aggregate rated envelope of Rs 1,880 Crores, derived from the disclosed long- and short-term limits.^{[1] [1]} The filing does not disclose the previous rating, so the direction of the revision—upgrade or downgrade—cannot be determined from the announcement alone.

Impact on debt cost

• Existing debt: There is no disclosed immediate interest-rate reset, covenant trigger or lender repricing. Therefore, the current cost of debt cannot be quantified from the rating announcement. The actual weighted-average borrowing rate, benchmark spread and rating-linked pricing clauses are not reported.
• New or refinanced debt: RWD can weaken negotiating leverage with lenders. Banks may price incremental exposure more conservatively or require additional security, even though the assigned rating continues to provide a formal credit assessment.
• Balance-sheet context: In Q1 FY27, consolidated total debt was Rs 532.41 Crores, including Rs 412.79 Crores of current borrowings and Rs 119.62 Crores of non-current borrowings; net debt was Rs 442.91 Crores.^{[2] [3] [4] [5]} TTM consolidated net debt/EBITDA was 1.86x and interest coverage was 4.63x.^{[6] [7]} These metrics do not indicate the rate impact directly, but they are relevant inputs to any lender reassessment.

Impact on additional bank guarantees

The short-term rating covers Rs 350 Crores of short-term bank facilities, but the filing does not split this amount between bank guarantees, letters of credit and other short-term facilities, nor does it disclose utilisation or unutilised headroom.^[1] Consequently, the available capacity for additional non-fund-based limits cannot be calculated.

For execution, the key risk is therefore availability rather than only interest expense:

• Banks may cap incremental BG limits, seek higher cash margins or additional collateral, or require tighter monitoring.
• If existing limits are already substantially utilised, RWD could make expansion slower even without a formal downgrade.
• A positive resolution of the watch would likely reduce this friction; an adverse resolution could further increase pricing and constrain guarantee capacity. This is a scenario implication, not company guidance.

Because guarantees do not initially create a cash loan, their cost is mainly commission and collateral-related; the larger economic risk is that insufficient BG capacity delays contractual mobilisation, milestone compliance or order execution. The rating filing does not report any current rejection, reduction or enhancement of Apollo’s guarantee limits. Thus, the decisive follow-up disclosures are the BG/LC sub-limit, utilisation, sanctioned headroom, cash-margin requirement and lender terms after the RWD action.

The current CAREedge interest-coverage and debt-to-EBITDA figures, as well as the rating-improvement thresholds, are not contained in the cited CAREedge communication. The filing only records that CARE placed the ratings on “Rating Watch with Developing implications”: CARE A- for Rs 1,530 Crores of long-term facilities and CARE A2+ for Rs 350 Crores of short-term facilities ^[1].

The closest disclosed previous rating-cycle reference is the September 2022 Acuité rationale:

• Interest coverage: 2.70x in FY2022 versus 2.45x in FY2021 ^[8].
• Debt-to-EBITDA: not reported in that rationale; it disclosed debt/equity of 0.36x for FY2022 versus 0.38x for FY2021 ^[8].
• A third-party data point reports debt-to-EBITDA of 2.52x in Mar-25, described as the highest level in the reported period, with a 5.11% decline versus the previous financial year ^[9]. This is not sufficient to establish the current CARE-defined ratio or to make a like-for-like comparison with the 2022 Acuité cycle.

Implication: the available evidence does not support saying whether the current interest coverage is above or below the prior 2.70x level, nor whether current debt-to-EBITDA has returned to or improved on the previous cycle’s position. Likewise, CARE’s specific deleveraging milestones—such as a target interest-coverage floor, debt-to-EBITDA ceiling, debt-reduction amount, or cash-flow trigger—are not disclosed in the retrieved filing. The current action should therefore be read as rating uncertainty, rather than as evidence of a defined upgrade path.